A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy

BACKGROUND: Nucleos(t)ide analogues reduce the incidence of hepatitis B virus (HBV) reactivation in cancer patients undergoing systemic cytotoxic chemotherapy but the experience of solid tumors remains limited. Aims. The aim of this study was to compare the efficacy of entecavir and lamivudine in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wen-Chi, Cheng, Jin-Shiung, Chiang, Po-Hung, Tsay, Feng-Woei, Chan, Hoi-Hung, Chang, Hsueh-Wen, Yu, Hsien-Chung, Tsai, Wei-Lun, Lai, Kwok-Hung, Hsu, Ping-I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488285/
https://www.ncbi.nlm.nih.gov/pubmed/26121480
http://dx.doi.org/10.1371/journal.pone.0131545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488285/
https://www.ncbi.nlm.nih.gov/pubmed/26121480
http://dx.doi.org/10.1371/journal.pone.0131545

Ejemplares similares